tetano
Editor, Senior Moderator
Thorac Res Pract
. 2024 Jul;25(4):162-167.
doi: 10.5152/ThoracResPract.2024.23117.. Evaluation of Long-Coronavirus Disease 2019 Cases Readmitted to Intensive Care Units Due to Acute Respiratory Failure: Point Prevalence Study
Eylem Tunçay[SUP] 1 [/SUP], Özlem Moçin[SUP] 2 [/SUP], Özlem Ediboğdu[SUP] 3 [/SUP], Nalan Adıgüzel[SUP] 2 [/SUP], Sinem Güngör[SUP] 2 [/SUP], İnşa İşcanlı[SUP] 4 [/SUP], Berrin Er[SUP] 5 [/SUP], Nilgin Alptekinoğlu Mendil[SUP] 6 [/SUP], Adnan Usalan[SUP] 7 [/SUP], Didem Yılmaz[SUP] 7 [/SUP], Hülya Keskin[SUP] 8 [/SUP], Gül Erdal Dönmez[SUP] 2 [/SUP], Barış Yılmaz[SUP] 2 [/SUP], Feyza Kargın[SUP] 8 [/SUP], Kemal Tolga Saraçoğlu[SUP] 8 [/SUP], Şahin Temel[SUP] 9 [/SUP], Hayriye Cankar Dal[SUP] 5 [/SUP], Sema Turan[SUP] 5 [/SUP], Leyla Talan[SUP] 10 [/SUP], Derya Hoşgün[SUP] 11 [/SUP], Semih Aydemir[SUP] 11 [/SUP], Hülya Sungurtekin[SUP] 12 [/SUP]
Affiliations
Objective: Coronavirus disease 2019 (COVID-19) caused morbidity and mortality worldwide. Besides the acute effects, subacute and long-term effects are defined as long-COVID causing morbidity. The intensive care unit (ICU) data of long-COVID-19 cases were evaluated with the participation of 11 centers.
Material and methods: Study was designed by Turkish Thoracic Society Respiratory Failure and Intensive Care Working Group to evaluate long COVID-19 patients. All patients followed up in the ICU with long-COVID diagnosis were included in point prevelance study.
Results: A total of 41 long COVID-19 patients from 11 centers were included in the study. Half of the patients were male, mean age was 66 ± 14, body mass index was 27 ± 5. Hypertension, diabetes mellitus, lung cancer, malignancy, and heart failure rates were 27%, 51%, 34%, 34%, and 27%, respectively. Eighty percent had received COVID vaccine. Patients had moderate hypoxemic respiratory failure. APACHE II, SOFA score was 18 (14-26), 6 (3-8), respectively. Forty-six percent received invasive mechanical ventilator support, 42% were sepsis, 17% were septic shock. Bilateral (67%), interstitial involvement (37%) were most common in chest x-ray. Fibrosis (27%) was detected in thorax tomography. Seventy-one percent of patients received antibiotherapy (42% carbapenem, 22% linezolid). Sixty-one percent of the patients received corticosteroid treatment.
Conclusion: More than half of the patients had pneumonia and the majority of them used broad-spectrum antibiotics. Presence of comorbidities and malignancies, intensive care severity scores, intubation, and sepsis rates were high. Receiving corticosteroid treatment and extensive bilateral radiologic involvement due to COVID-19 might be the reasons for the high re-admission rate for the ICUs.
. 2024 Jul;25(4):162-167.
doi: 10.5152/ThoracResPract.2024.23117.. Evaluation of Long-Coronavirus Disease 2019 Cases Readmitted to Intensive Care Units Due to Acute Respiratory Failure: Point Prevalence Study
Eylem Tunçay[SUP] 1 [/SUP], Özlem Moçin[SUP] 2 [/SUP], Özlem Ediboğdu[SUP] 3 [/SUP], Nalan Adıgüzel[SUP] 2 [/SUP], Sinem Güngör[SUP] 2 [/SUP], İnşa İşcanlı[SUP] 4 [/SUP], Berrin Er[SUP] 5 [/SUP], Nilgin Alptekinoğlu Mendil[SUP] 6 [/SUP], Adnan Usalan[SUP] 7 [/SUP], Didem Yılmaz[SUP] 7 [/SUP], Hülya Keskin[SUP] 8 [/SUP], Gül Erdal Dönmez[SUP] 2 [/SUP], Barış Yılmaz[SUP] 2 [/SUP], Feyza Kargın[SUP] 8 [/SUP], Kemal Tolga Saraçoğlu[SUP] 8 [/SUP], Şahin Temel[SUP] 9 [/SUP], Hayriye Cankar Dal[SUP] 5 [/SUP], Sema Turan[SUP] 5 [/SUP], Leyla Talan[SUP] 10 [/SUP], Derya Hoşgün[SUP] 11 [/SUP], Semih Aydemir[SUP] 11 [/SUP], Hülya Sungurtekin[SUP] 12 [/SUP]
Affiliations
- PMID: 39128056
- DOI: 10.5152/ThoracResPract.2024.23117.
Objective: Coronavirus disease 2019 (COVID-19) caused morbidity and mortality worldwide. Besides the acute effects, subacute and long-term effects are defined as long-COVID causing morbidity. The intensive care unit (ICU) data of long-COVID-19 cases were evaluated with the participation of 11 centers.
Material and methods: Study was designed by Turkish Thoracic Society Respiratory Failure and Intensive Care Working Group to evaluate long COVID-19 patients. All patients followed up in the ICU with long-COVID diagnosis were included in point prevelance study.
Results: A total of 41 long COVID-19 patients from 11 centers were included in the study. Half of the patients were male, mean age was 66 ± 14, body mass index was 27 ± 5. Hypertension, diabetes mellitus, lung cancer, malignancy, and heart failure rates were 27%, 51%, 34%, 34%, and 27%, respectively. Eighty percent had received COVID vaccine. Patients had moderate hypoxemic respiratory failure. APACHE II, SOFA score was 18 (14-26), 6 (3-8), respectively. Forty-six percent received invasive mechanical ventilator support, 42% were sepsis, 17% were septic shock. Bilateral (67%), interstitial involvement (37%) were most common in chest x-ray. Fibrosis (27%) was detected in thorax tomography. Seventy-one percent of patients received antibiotherapy (42% carbapenem, 22% linezolid). Sixty-one percent of the patients received corticosteroid treatment.
Conclusion: More than half of the patients had pneumonia and the majority of them used broad-spectrum antibiotics. Presence of comorbidities and malignancies, intensive care severity scores, intubation, and sepsis rates were high. Receiving corticosteroid treatment and extensive bilateral radiologic involvement due to COVID-19 might be the reasons for the high re-admission rate for the ICUs.